Director; Global Value, Access & Pricing; Solid Tumors, Pipeline
BeOne Medicines
About this role
This role is a senior strategic position focused on developing market access and pricing strategies for pipeline solid tumor products in the oncology field. It involves coordinating cross-functional efforts to optimize product value, reimbursement, and market access throughout clinical development and pre-launch phases.
Skills
About BeOne Medicines
beonemedicines.comBeOne Medicines is committed to developing innovative cancer medicines by partnering globally to serve patients everywhere. Formerly known as BeiGene.
Recent company news
BeOne Medicines Updates on Employee Share Purchase Plan Uptake
4 hours ago
Assessing BeOne Medicines (ONC) Valuation After Profit Turnaround And Optimistic 2026 Guidance
1 day ago
Capital International Investors Boosts Stake in BeOne Medicines Ltd. - Sponsored ADR $ONC
2 days ago
BeOne Medicines Pharma Alliances Contrast With High P/E And Valuation Upside
1 week ago
Senhwa Biosciences and BeOne Medicines Announces a Clinical Supply Agreement to Address the Challenge of Cold Tumors
Dec 10, 2025
About BeOne Medicines
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for BeOne Medicines.
Salary
$100k – $200k
per year
More jobs at BeOne Medicines
Similar Jobs
Senior Director, Global Market Access and Pricing, Solid Tumor
Genmab
Director, Global Market Access & Pricing
Genmab
Global Value and Access Lead, Solid Tumors, Oncology Business Unit
Takeda Pharmaceutical Company
Director Global Market Access Oncology (Hematology)
MSD
Director, Global Access Strategy & Pricing, Oncology Pipeline & BD
Pfizer
Vice President -Global Brand Lead Commercialization, Solid Tumors
Genmab